The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma.

CONCLUSION: Our study provides evidence that inhibiting lncRNA MALAT-1 can improve the chemotherapy sensitivity of DLBCL by enhancing autophagy-related proteins. PMID: 28292022 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28292022?dopt=Abstract

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - March 7, 2017 Category: Drugs & Pharmacology Authors: Li LJ, Chai Y, Guo XJ, Chu SL, Zhang LS Tags: Biomed Pharmacother Source Type: research

More News: Chemotherapy | Drugs & Pharmacology | Genetics | Lymphoma | Study